2009
- Seya T., and K. Miyake. 2009. Toll-like receptor.Encyclopedia of Molecular
Medicine(Nature Publishing Group) Ed. by T. E. Creighton. John Wiley & Sons,
Inc. New York, NY a0004028. www.els.net.
- Watanabe, T., K. Ito, M. Matsumoto, T. Seya, K. Hatakeyama, S. Nishikawa, T.
Hasegawa, and K. Fukuda. 2009. Isolation and Characterization of RNA aptamers
specific for the human Toll-like receptor 3 ectodomain. Viva Origino.
37: 10-18.
- Oshiumi, H., M. Matsumoto, S. Hatakeyama, and T. Seya. 2009. Riplet/RNF135,
a RING-finger protein, ubiquitinates RIG-I to promote interferon-b induction during
the early phase of viral infection. J. Biol. Chem. 284:
807-817.
- Wu, J. D., C. L. Atteridge, X. J. Wang, T. Seya, and S. R. Plymate. 2009.
Obstructing shedding of the immune stimulatory MHC class I chain-related gene B
prevents tumor formation. Clin. Cancer Res. 15: 632-640.
- Oshiumi, H., Y. Suzuki, M. Matsumoto, and T. Seya. 2009. Regulator of Complement
Activation (RCA) gene cluster in Xenopus tropicalis. Immunogenetics
61:371-384.
- Akao, Y., T. Ebihara, H. Masuda, Y. Saeki, K. Hazeki, O. Hazeki, M. Matsumoto,
and T. Seya. 2009. Enhancement of antitumor natural killer cell activation by orally
administered Spirulina extract in mice. Cancer Sci. 100:1494-1501.
- Fujimoto, Y., M. Hashimoto, M. Furuyashiki, M. Katsumoto, T. Seya, Y. Suda,
andK. Fukase. 2009. Innate Immunostimulatory lipopepitdes of Staphylococcus aureus
as TLR2 ligands; Prediction with mRNA expression, chemical synthesis and immunostimulatory
activities.Chem. Biol. Chem. 10: 2311-2315.
- Yasukawa, K., H. Oshiumi, M. Takeda, Y. Yanagi, T. Seya, S. Kawabata and T.
Koshiba. 2009. Mitofusin 2, a mitochondrial fusion mediator, acts as a negative
regulator for mitochondrial antiviral signaling. Science Signaling.
2(84): ra47.
- Kodama, K., M. Higashiyama, K. Takami, K. Oda, J. Okami, J. Maeda, T. Akazawa,
M. Matsumoto, T. Seya, M. Wada, A. Hayashi, and K. Toyoshima. 2009. Innate immune therapy
with a BCG cell wall skeleton after radical surgery for non-small cell lung cancer:
a case-control study. Surgery Today. 39: 194-200.
- Takaki, H., H. Oshiumi, T. Kawanishi, M. Sasai, M. Matsumoto, and T. Seya. 2009.
Cytoplasmic oligomerized TICAM-1 recruits nuclear BS69 to enhance type I interferon
induction.Eur. J. Immunol.39: 3469-3476.
- Iwakiri. D.,L. Zhou, M. Samanta, M. Matsumoto, T. Ebihara, T. Seya, S. Imai, M.
Fujieda, K. Kawa, and K. Takada. 2009. Epstein-Barr virus (EBV)-encoded small RNA
is released from EBV-infected cells and activates signaling from Toll-like receptor 3.
J.
Exp. Med. 206: 2091-2099.
- Seya, T., M. Matsumoto, T. Ebihara, and H. Oshiumi. 2009. Functional evolution
of the TICAM-1 (TRIF) pathway for extrinsic RNA sensing. Immunol. Rev.
227:
44-53 (review).
- Seya, T., and M. Matsumoto. 2009. The extrinsic RNA-sensing pathway for adjuvant
immunotherapy for cancer. Cancer Immunol. Immunother. 58:1175-
1184 (review).
- Ebihara, T. M. Matsumoto, and T. Seya. 2009. Dendritic cell/NK cell interaction
in RNA virus infection. Curr. Immunol. Rev. 5: 200-207
(review).